Valcreate Investment Life Sciences and Specialty Opportunities Strategy
|Year of Inception||2018|
|Number of Stocks||10|
|Investment Horizon||Long Term|
|Fund Managers||Mr. Rajesh Pherwani|
About Fund Managers
Mr Pherwani, the fund manager of Valcreate Investment Life Sciences and Speciality Opportunities Strategy, started his career with HDFC. In his early years, he worked as an investment analyst, and later as Head of Analysis and Fund Manager. He has 24+ years of experience in the investment industry and has established a stable base for Valcreate’s investment processes.
Investing in life sciences companies
- Valcreate Investment Life Sciences and Speciality Opportunities PMS aims to invest in a stock portfolio using a buy-and-hold strategy with sufficient diversification to minimise risk.
- The strategy entails investing in enterprises that deliver creative goods and services, giving them a competitive advantage in the long run.
- These businesses would earn at least 70% of the strategy’s portfolio investment. It will be considered a more volatile portfolio.
Disclaimer: Investing Involves Risk. This document is for information purposes only and should not be viewed as a legal offering document or solicitation. Offers to invest in this fund are made only by the Discretionary Portfolio Management Services Agreement. Past performance does not guarantee future results and there is no assurance that the managed accounts will necessarily achieve their objectives. We do not guarantee any returns in the hand of investors not we take any sort of accountability for the performance of the scheme. The above-mentioned data is collected from the respected Fund house please verify the same at SEBI website.